Alpine’s proprietary technology platforms enable the development of engineered proteins optimized to modulate multiple immune cell receptors within the immune synapse. Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. The Investor Relations website contains information about Alpine Immune Sciences's business for stockholders, potential investors, and financial analysts. Alpine Immune Sciences, Inc. focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Developing new therapies to improve the lives of real patients that are suffering, problem solving every day with an incredibly smart, fun, and engaging team, meeting wonderful people and building long term relationships inside and outside of Alpine, and working at the leading-edge of immunobiology research.”, “I feel motivated at Alpine because everyone, including myself, is genuinely curious about the science world. All content is posted anonymously by employees working at Alpine Immune Sciences. PDF Version. We have weekly get-togethers at local beer halls, a casual and stocked breakroom, monthly company lunches, peer-to-peer recognition programs, weekly fitness and yoga classes, and more. Join us! Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. Alpine Immune Sciences focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. I discovered quickly that it would be the people with whom I have the pleasure of working that I found most motivating. More Details. Alpine Immune Sciences focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. And we find the time to have fun and celebrate the achievements of one another, big and small.”, “I like the mindset of the people in these labs. Alpine Immune Sciences to report fourth quarter and full year 2020 financial results and provide a corporate opdate… twitter.com/i/web/status/13701…, Dr. Mark Voskobynik @_vosko will be presenting a Trials In Progress poster at #AACR21 on ALPN-202, our first-in-cl… twitter.com/i/web/status/13697…. To access the live call by phone, dial (800) 816-3005 (domestic) or (857) 770-0069 (international) and reference conference ID: 2539338. I enjoy working with my colleagues and appreciate how smart and talented they are every day.”, “Alpine has given me the opportunity to work and collaborate with many talented groups of people that offer a great deal of knowledge and experience. The Investor Relations website contains information about Alpine Immune Sciences's business for stockholders, potential investors, and financial analysts. A replay of the presentation will be available on the company website for 90 days following the webcast. Every day I realize how lucky I am to work at Alpine.”, “Getting to spend every day at Alpine with such nice people. 619-916-7620 To foster our team of outstanding scientists and business professionals, we provide a premier work environment with a state-of-the-art lab and office spaces with truly inspiring views and an open design to facilitate teamwork. Real time Alpine Immune Sciences, Inc. (ALPN) stock price quote, stock graph, news & analysis. Learning and participating in applying those skills towards bettering lives and making a difference has been one of my main motivators.”, “Working with such amazingly bright, caring, considerate, and engaging colleagues, and working on such incredibly interesting and promising projects motivates me so (+++) much!! Gilmartin Group, LLC. Alpine Immune Sciences announces $60 million private placement led by Omega Funds with participation from Avidity Partners, EcoR1 Capital, LLC, Invus Public Equities, LP, and Samsara BioCapital, among others. I’m in awe of the business and science work that happens every day!”, “The team at Alpine is passionate and dedicated towards making advances in science to improve and save patients’ lives. Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101 . Alpinists share a passion for meaningful work and are committed to solving the most complex problems in immunology to create new therapies for patients. Our treasured culture has been shaped by our diverse team who truly enjoys working and playing together. Alpine Immune Sciences, Inc. is committed to leading a new wave of functional immune therapeutics. Find the latest Alpine Immune Sciences, Inc. (ALPN) stock quote, history, news and other vital information to help you with your stock trading and investing. It’s a privilege to work with everyone here on a daily basis. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine endeavors to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. I like the ownership that we all take for our work. On top of all this, there is never a dull moment. Together we strive every day to make a difference in patients’ lives. SEATTLE--(BUSINESS WIRE)--Mar. 1 motivation to work at Alpine is definitely the people that I am working with. Alpinists with great scientific minds, expertise in their respective areas and ‘one team’ attitude make me hopeful that we are empowered to have meaningful contributions in science. As much as we plan, a study can be taken in a completely different direction at any point. Follow @AlpineImmuneSci on Twitter and LinkedIn. A live webcast of the presentation will be available online in the investor relations section of the company’s website at https://ir.alpineimmunesciences.com/events. SEATTLE --(BUSINESS WIRE)--Feb. 22, 2021-- Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced the company will participate at … Working at Alpine truly is a team effort, and I’m honored to be part of this team.”, “I like the team spirit – there’s team ambition as opposed to individual ambition. Not only are we able to generate a ton of data, but we are also able to execute studies without mistakes. It is engaged in discovering and developing modern, protein-based immunotherapies targeting the immune synapse to … I get to have a bit of a bird’s eye view of all that is going on, and yet get to do small things that hopefully make an impact on the office. We believe quality time outside the office is vital to our employees’ satisfaction at work. Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101. Find the latest Alpine Immune Sciences, Inc. (ALPN) stock quote, history, news and other vital information to help you with your stock trading and investing. The focus is on the science and moving projects forward without biases introduced by people’s career aspirations.”, “My No. “Secreted Immunomodulatory Proteins,” “SIP,” “Transmembrane Immunomodulatory Protein,” “TIP,” “Variant Ig Domain,” “vIgD” and the Alpine logo are registered trademarks or trademarks of Alpine Immune Sciences, Inc. in various jurisdictions. Leading the Next Evolution of Immunotherapies. Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. Rewards. First, I love the scientific process and the necessary problem solving needed to do good science – figuring out an unexpected result can be the highlight of my day! Alpine Immune Sciences stock rose more than 10% Friday after the Seattle-based biotech company inked a $60 million licensing deal with pharmaceutical giant AbbVie for its lupus drug. It didn’t feel like I was interviewing – it felt like talking to people I’ve known for a long time.”, “Alpine is my first biotech experience and I am constantly learning every day, which is exciting. © 2021 Alpine Immune Sciences. Get alerts on ALPN - Alpine Immune Sciences, Inc. I strive to be a better teammate because of everyone’s determination to succeed and compassionate personalities.”, “The most rewarding part of my career so far is the opportunity to learn and engage with an amazing set of coworkers and to work at a company that is developing therapies that will hopefully change people’s lives.”, “It is a wonderful opportunity to work with such a talented group of people to bring great science into the clinic. Alpine Immune Sciences, Inc. focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Alpine Immune Sciences announces $60 million private placement led by Omega Funds with participation from Avidity Partners, EcoR1 Capital, LLC, Invus Public Equities, LP, and Samsara BioCapital, among others. For more information, visit www.alpineimmunesciences.com. SEATTLE--(BUSINESS WIRE)-- Alpine Immune Sciences Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced the planned presentation of two posters at the American Association for Cancer Research (AACR) Virtual Annual Meeting I, taking place April 10-15, … Alpine Immune Sciences recently initiated a strategic partnership with AbbVie for the development of Alpine’s first-in class novel immunotherapeutic, ALPN‑101. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is creating first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine is … Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101 . About Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc. is committed to leading a new wave of functional immune therapeutics. The level of dedication and enthusiasm, combined with critical thinking, is motivating and awe-inspiring! I never imagined being able to run as many pharmacology studies as we do. About Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. And hopefully Alpine can help a lot of patients to have a better quality of life.”, “I knew I wanted to work at Alpine about 15 minutes into a 1-hour conversation with Stanford! Alpine Immune Sciences, Inc. focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and … I felt I was in great company on the science side, and everyone seemed to be very professional and welcoming. Alpinists are so friendly, kind to each other, and very supportive.”, “When I interviewed at Alpine, I was very impressed by the experience. Although still a year away from treating afflicted patients, Alpine’s novel approach could result in game-changing therapies down the road. They share this passion, work with a sense of urgency, and operate with a high level of excellence. “The high-quality research, the great group of brilliant teammates, and the possibility of changing people’s lives to make them better. I can feel the motivation, dedication, and commitment everyone has towards making a difference.”, “I am a people person who is motivated by working within a group to achieve specific goals and projects, so Alpine’s team-drive culture is very exciting to me!”, “Two things motivate me. Alpine is located in Seattle’s vibrant Eastlake neighborhood, the epicenter of biotech in Washington State. Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. The Investor Relations website contains information about Alpine Immune Sciences's business for stockholders, potential investors, and financial analysts. Apart from work, what I appreciate a lot is the fact that I am encouraged to take care of myself through initiatives like step challenge, yoga Fridays, etc. Alpine Immune Sciences is developing next-generation immunotherapies to treat cancer and autoimmune disorders. Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics, creating potentially powerful multifunctional immunotherapies to … - Alpine Immune Sciences grants AbbVie option to license worldwide rights to ALPN-101, a phase 2-ready, first-in-class dual CD28/ICOS costimulation antagonist, building on AbbVie’s commitment to developing novel therapies in …